Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-020944
Filing Date
2017-04-18
Accepted
2017-04-18 18:01:06
Documents
2
Period of Report
2017-04-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 v464423_3.html 3  
1 FORM 3 v464423_3.xml 3 1632
2 EXHIBIT 24 v464423_ex24.htm EX-24 3454
  Complete submission text file 0001144204-17-020944.txt   6599
Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 617-244-1616
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 WEST WATKINS MILL ROAD GAITHERSBURG MD 20878
Business Address
Swirsky Douglas J (Reporting) CIK: 0001375884 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36598 | Film No.: 17767794